|
BEDOGNETTI D.-ZOPPOLI G.-MASSUCCO C.-ZANARDI E.-ZUPO S.-BRUZZONE
A.-SERTOLI M.R.-BALLEARI E.-RACCHI O.-MESSINA M.-CALTABIANO G.-
ICARDI G.-DURANDO P.-MARINCOLA F.-BOCCARDO F.-FERRARINI M.-ANSALDI
F.-DE MARIA A.
Impaired response to influenza vaccine associated with persistent
memory B cell depletion in non Hodgkin's lymphoma patients treated
with rituximab containing regimens.
J. Immunol. 186:6044/6055, 2011
PubMed Abstract
BRUZZONE M.-CENTURIONI M.G.-GIGLIONE P.-GUALCO M.-MERLO D.F.-
MIGLIETTA L.-COSSO M.-GIANNELLI F.-CRISTOFORONI P.-FERRARINI M.
Second line treatment with intravenous gemcitabine and oral
etoposide in platinum resistant advanced ovarian cancer patients:
results of a phase II study.
Oncology 80:238/246, 2011
PubMed Abstract
COLOMBO M.-CUTRONA G.-REVERBERI D.-FABRIS S.-NERI A.-FABBI M.-
QUINTANA G.-QUARTA G.-GHIOTTO F.-FAIS F.-FERRARINI M.
Intraclonal cell expansion and selection driven by B cell receptor
in chronic lymphocytic leukemia.
Mol. Med. 17(7/8):834/839, 2011
PubMed Abstract
FABRIS S.-BOLLATI V.-AGNELLI L.-MORABITO F.-MOTTA V.-CUTRONA G.-
MATIS S.-RECCHIA A.-GIGLIOTTI V.-GENTILE M.-LAMBERTENGHI DELILIERS
G.-BERTAZZI P.-FERRARINI M.-NERI A.-BACCARELLI A.
Biological and clinical relevance of quantitative global
methylation of repetitive DNA sequences in chronic lymphocytic
leukemia.
Epigenetics 6(2):188/194, 2011
PubMed Abstract
FABRIS S.-SCARCIOLLA O.-MORABITO F.-CIFARELLI R.-DININNO C.-
CUTRONA G.-MATIS S.-RECCHIA A.-GENTILE M.-CICERI G.-FERRARINI M.-
CIANCIO A.-MANNARELLA C.-NERI A.-FRAGASSO A.
Multiplex ligation dependent probe amplification and fluorescence
in situ hybridization to detect chromosomal abnormalities in
chronic lymphocytic leukemia: a comparative study.
Genes Chromosomes Cancer 50:726/734, 2011
PubMed Abstract
FERRETTI E.-BERTOLOTTO M.-DEAGLIO S.-TRIPODO C.-RIBATTI D.-AUDRITO
V.-BLENGIO F.-MATIS S.-ZUPO S.-ROSSI D.-OTTONELLO L.-GAIDANO G.-
MALAVASI F.-PISTOIA V.-CORCIONE A.
A novel role of the CX(3)CR1/CX(3)CL1 system in the cross talk
between chronic lymphocytic leukemia cells and tumor
microenvironment.
Leukemia 25:1268/1277, 2011
PubMed Abstract
BEDOGNETTI D.-ZOPPOLI G.-SERTOLI M.R.-ZANARDI E.-BLANDINI P.-
UCCELLINI L.-BOCCARDO F.-ANDREOLI G.B.-GHIO R.-RACCHI O.-FERRARINI
M.-DE MARIA A.
Relevance of HBV/HBcAb screening in lymphoma patients treated in
the Rituximab era. Letter.
Int. J. Hematol. 91:342/344, 2010
PubMed Abstract
BRIGATI C.-BANELLI B.-CASCIANO I.-DI VINCI A.-MATIS S.-CUTRONA G.-
FORLANI A.-ALLEMANNI G.-ROMANI M.
Epigenetic mechanisms regulate DeltaNP73 promoter function in
human tonsil B cells.
Mol. Immunol. 48:408/414, 2011 - Epub Dec 1, 2010
PubMed Abstract
CHIORAZZI N.-FERRARINI M.
Cellular origin(s) of chronic lymphocytic leukemia: cautionary
notes and additional considerations and possibilities.
Blood 117(6):1781/1791, 2011 - Epub Dec 9, 2010
PubMed Abstract
DE TOTERO D.-CAPAIA M.-FABBI M.-CROCE M.-MEAZZA R.-CUTRONA G.-ZUPO
S.-LOIACONO F.-TRUINI M.-FERRARINI M.-FERRINI S.
Heterogeneous expression and function of IL/21R and susceptibility
to IL/21 mediated apoptosis in follicular lymphoma cells.
Exp. Hematol. 38:373/383, 2010
PubMed Abstract
LAURENT S.-CARREGA P.-SAVERINO D.-PICCIOLI P.-CAMORIANO M.-
MORABITO A.-DOZIN B.-FONTANA V.-SIMONE R.-MORTARA L.-MINGARI M.C.-
FERLAZZO G.-PISTILLO M.P.
CTLA/4 is expressed by human monocyte derived dendritic cells and
regulates their functions.
Hum. Immunol. 71:934/941, 2010
PubMed Abstract
MIGLIETTA L.-CANOBBIO L.-PARODI M.A.-ANSELMI L.
Unusual osteoblastic secondary lesion as predominant metastatic
disease spread in two cases of uterine leiomyosarcoma.
Case Rep. Oncol. 3:49/53, 2010
PubMed Abstract
MIGLIETTA L.-VANELLA P.-REZZO R.-CARLI F.-SPINA B.
A 37 year old woman with spindle cells metaplastic breast
carcinoma: a case characterized by very aggressive clinical
behavior.
Breast J. 16(3):315/317, 2010
PubMed Abstract
MOLICA S.-DIGIESI G.-BATTAGLIA C.-CUTRONA G.-ANTENUCCI A.-MOLICA
M.-GIANNARELLI D.-SPERDUTI I.-GENTILE M.-MORABITO F.-FERRARINI M.
Baff serum level predicts time to first treatment in early chronic
lymphocytic leukemia.
Eur. J. Haematol. 85:314/320, 2010
PubMed Abstract
MOLICA S.-DI RAIMONDO F.-CUTRONA G.-FABRIS S.-MAURO F.-BRUGIATELLI
M.-BALDINI L.-MUSTO P.-SACCHI S.-CORTELEZZI A.-FOA' R.-NERI A.-
FEDERICO M.-FERRARINI M.-MORABITO F.-Gruppo Italiano Studio
Linfomi (GISL)
Clinical categories identified by a new prognostic index reflect
biological characteristics of patients in early chronic
lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL)
experience. Letter.
Leuk. Res. 34:e217/e218, 2010
PubMed Abstract
MORABITO F.-CUTRONA G.-GENTILE M.-LOIACONO F.-MATIS S.-RECCHIA A.-
GIGLIOTTI V.-CALLEA V.-ZUPO S.-FERRARINI M.
More on the determination of Ki/67 as a novel potential prognostic
marker in B cell chronic lymphocytic leukemia. Letter.
Leuk. Res. 34:e326/e328, 2010
PubMed Abstract
MOSCA L.-FABRIS S.-LIONETTI M.-TODOERTI K.-AGNELLI L.-MORABITO F.-
CUTRONA G.-ANDRONACHE A.-MATIS S.-FERRARI F.-GENTILE M.-SPRIANO M.-
CALLEA V.-FESTINI G.-MOLICA S.-LAMBERTENGHI DELILIERS G.-BICCIATO
S.-FERRARINI M.-NERI A.
Integrative genomics analyses reveal molecularly distinct
subgroups of B cell chronic lymphocytic leukemia patients with
13q14 deletion.
Clin. Cancer Res. 16(23):5641/5653, 2010
PubMed Abstract
ORENGO A.M.-FABBI M.-MIGLIETTA L.-ANDREANI C.-BRUZZONE M.-PUPPO A.-
CRISTOFORONI P.-CENTURIONI M.G.-GUALCO M.-SALVI S.-BOCCARDO S.-
TRUINI M.-PIAZZA T.-CANEVARI S.-MEZZANZANICA D.-FERRINI S.
Interleukin (IL)/18, a biomarker of human ovarian carcinoma, is
predominantly released as biologically inactive precursor.
Int. J. Cancer 129:1116/1125, 2011 - Epub Nov 8, 2010
PubMed Abstract
PERUZZI B.-SERRA M.-PESCUCCI C.-SICA M.-LASTRAIOLI S.-RONDELLI T.-
PEDEMONTE S.-RISITANO A.-DE ANGIOLETTI M.-PICCIOLI P.-NOTARO R.
Easy genotyping of complement C3 slow and fast allotypes by tetra
primer amplification refractory mutation system PCR.
Mol. Cell. Probes 24:401/402, 2010
PubMed Abstract
CRO L.-MORABITO F.-ZUCAL N.-FABRIS S.-LIONETTI M.-CUTRONA G.-ROSSI
F.-GENTILE M.-FERRARIO A.-FERRARINI M.-MOLICA S.-NERI A.-BALDINI L.
CD26 expression in mature B cell neoplasia: its possible role as a
new prognostic marker in B/CLL.
Hematol. Oncol. 27:140/147, 2009
PubMed Abstract
FRANCHELLI S.-LEONE M.S.-BRUZZONE M.-MUGGIANU M.-PUPPO A.-
GUSTAVINO C.-DI CAPUA E.-CENTURIONI M.G.
The gluteal fold fascio cutaneous flap for reconstruction after
radical excision of primary vulvar cancers.
Gynecol. Oncol. 113:245/248, 2009
PubMed Abstract
GENTILE M.-CUTRONA G.-NERI A.-MOLICA S.-FERRARINI M.-MORABITO F.
Predictive value of beta2/microglobulin (beta2/m) levels in
chronic lymphocytic leukemia since Binet A stages. Letter.
Haematologica 94:887/888, 2009
PubMed Abstract
MATIS S.-MARIANI M.R.-CUTRONA G.-CILLI M.-PICCARDI F.-DAGA A.-
DAMONTE G.-MILLO E.-MORONI M.-RONCELLA S.-FEDELI F.-BOFFA L.C.-
FERRARINI M.
PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in
a SCID mice model: cells dissemination similar to the human
disease.
Cancer Gene Ther. 16:786/793, 2009
PubMed Abstract
MIGLIETTA L.-VANELLA P.-CANOBBIO L.-PARODI M.-GUGLIELMINI P.-
BOCCARDO F.
Clinical and pathological response to primary chemotherapy in
patients with locally advanced breast cancer grouped according to
hormonal receptors, Her2 status, grading and Ki/67 proliferation
index.
Anticancer Res. 29:1621/1626, 2009
PubMed Abstract
MOLICA S.-DIGIESI G.-MIRABELLI R.-CUTRONA G.-ANTENUCCI A.-MOLICA
M.-GIANNARELLI D.-SPERDUTI I.-MORABITO F.-NERI A.-BALDINI L.-
FERRARINI M.
Serum level of CD26 predicts time to first treatment in early B
chronic lymphocytic leukemia.
Eur. J. Haematol. 83:208/214, 2009
PubMed Abstract
MORABITO F.-CUTRONA G.-GENTILE M.-FABBI M.-MATIS S.-COLOMBO M.-
REVERBERI D.-MEGNA M.-SPRIANO M.-CALLEA V.-VIGNA E.-ROSSI E.-LUCIA
E.-FESTINI G.-ZUPO S.-MOLICA S.-NERI A.-FERRARINI M.
Prognostic relevance of in vitro response to cell stimulation via
surface IgD in binet stage a CLL. Letter.
Br. J. Haematol. 149:160/163, 2010 - Epub Dec 8, 2009
PubMed Abstract
MORABITO F.-CUTRONA G.-GENTILE M.-MATIS S.-TODOERTI K.-COLOMBO M.-
SONAGLIO C.-FABRIS S.-REVERBERI D.-MEGNA M.-SPRIANO M.-LUCIA E.-
ROSSI E.-CALLEA V.-MAZZONE C.-FESTINI G.-ZUPO S.-MOLICA S.-NERI A.-
FERRARINI M.
Definition of progression risk based on combinations of cellular
and molecular markers in patients with Binet stage A chronic
lymphocytic leukaemia.
Br. J. Haematol. 146:44/53, 2009
PubMed Abstract
PICCIOLI P.-BALBI G.-SERRA M.-MORABITO A.-LAMPARELLI T.-GOBBI M.-
LAURENT S.-DOZIN B.-BRUZZI P.-FERRARIS A.M.-BACIGALUPO An.-NOTARO
R.-PISTILLO M.P.
CTLA/4 +49A>G polymorphism of recipients of HLA matched sibling
allogeneic stem cell transplantation is associated with survival
and relapse incidence.
Ann. Hematol. 89:613/618, 2010 - Epub Dec 18, 2009
PubMed Abstract
TASSO R.-FAIS F.-REVERBERI D.-TORTELLI F.-CANCEDDA R.
The recruitment of two consecutive and different waves of host
stem/progenitor cells during the development of tissue engineered
bone in a murine model.
Biomaterials 31:2121/2129, 2010 - Epub Dec 21, 2009
PubMed Abstract
TORTELLI F.-TASSO R.-LOIACONO F.-CANCEDDA R.
The development of tissue engineered bone of different origin
through endochondral and intramembranous ossification following
the implantation of mesenchymal stem cells and osteoblasts in a
murine model.
Biomaterials 31:242/249, 2010 - Epub Sep 29, 2009
PubMed Abstract
CUTRONA G.-COLOMBO M.-MATIS S.-FABBI M.-SPRIANO M.-CALLEA V.-VIGNA
E.-GENTILE M.-ZUPO S.-CHIORAZZI N.-MORABITO F.-FERRARINI M.
Clonal heterogeneity in chronic lymphocytic leukemia cells:
superior response to surface IgM cross linking in CD38, ZAP/70
positive cells.
Haematologica 93:413/422, 2008
PubMed Abstract
FABRIS S.-MOSCA L.-TODOERTI K.-CUTRONA G.-LIONETTI M.-INTINI D.-
MATIS S.-COLOMBO M.-AGNELLI L.-GENTILE M.-SPRIANO M.-CALLEA V.-
FESTINI G.-MOLICA S.-LAMBERTENGHI G.-MORABITO F.-FERRARINI M.-NERI
A.
Molecular and transcriptional characterization of 17p loss in B
cell chronic lymphocytic leukemia.
Genes Chromosomes Cancer 47:781/793, 2008
PubMed Abstract
MOLICA S.-DIGIESI G.-MAURO F.-MIRABELLI R.-CUTRONA G.-VITELLI G.-
MORABITO F.-IULIANO F.-FOA' R.-FERRARINI M.
Increased serum BAFF (B cell activating factor of the TNF family)
level is a peculiar feature associated with familial chronic
lymphocytic leukemia.
Leuk. Res. 33:162/165, 2009 - Epub Jun 13, 2008
PubMed Abstract
MOLICA S.-VITELLI G.-CUTRONA G.-TODOERTI K.-MIRABELLI R.-DIGIESI
G.-GIANNARELLI D.-SPERDUTI I.-MOLICA M.-GENTILE M.-MORABITO F.-
NERI A.-FERRARINI M.
Prognostic relevance of serum levels and cellular expression of
adiponectin in B cell chronic lymphocytic leukemia.
Int. J. Hematol. 88:374/380, 2008
PubMed Abstract
MOLICA S.-VITELLI G.-CUTRONA G.-TODOERTI K.-MIRABELLI R.-DIGIESI
G.-MORABITO F.-NERI A.-FERRARINI M.
Serum thrombopoietin compared with ZAP/70 and immunoglobulin heavy
chain gene mutation status as a predictor of time to first
treatment in early chronic lymphocytic leukemia.
Leuk. Lymphoma 49:62/67, 2008
PubMed Abstract
PICCIOLI P.-SERRA M.-PEDEMONTE S.-BALBI G.-LOIACONO F.-LASTRAIOLI
S.-GARGIULO L.-MORABITO A.-ZUCCARO D.-DEL MASTRO L.-PISTILLO M.P.-VENTURINI M.-DE ANGIOLETTI M.-NOTARO R.
Hexaprimer amplification refractory mutation system PCR for
simultaneous single tube genotyping of 2 close polymorphisms.
Letter.
Clin. Chem. 54:227/229, 2008
PubMed Abstract
BALBI G.-FERRERA F.-RIZZI M.-PICCIOLI P.-MORABITO A.-CARDAMONE L.-GHIO M.-PALMISANO G.-CARRARA P.-PEDEMONTE S.-SESSAREGO M.-
DE ANGIOLETTI M.-NOTARO R.-INDIVERI F.-PISTILLO M.P.
Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen/4 (CTLA/4) gene polymorphisms with a clinical subset of
italian patients with systemic sclerosis.
Clin. Exp. Immunol. 149:40/47, 2007
PubMed Abstract
BOFFA L.-MENICHINI P.-BOLOGNESI C.-CUTRONA G.-RONCELLA S.-DAMONTE G.-MILLO E.-MARIANI M.-MATIS S.-RUSSO D.-CILIUTTI P.-FERRARINI M.
Lack of mutagenicity and clastogenicity of PNAEmu/NLS targeted to a regulatory sequence of the translocated c/myc oncogene in
Burkitt's lymphoma.
Mutat. Res. Gen. Tox. En. 628:129/137, 2007
PubMed Abstract
CUTRONA G.-BOFFA L.-MARIANI M.-MATIS S.-DAMONTE G.-MILLO E.-RONCELLA S.-FERRARINI M.
The peptide nucleic acid targeted to a regulatory sequence of the translocated c/myc oncogene in Burkitt's lymphoma lacks
immunogenicity: follow up characterization of PNAEmu/NLS.
Oligonucleotides 17:146/150, 2007
PubMed Abstract
DE TOTERO D.-MEAZZA R.-CAPAIA M.-FABBI M.-AZZARONE B.-BALLEARI E.-GOBBI M.-CUTRONA
G.-FERRARINI M.-FERRINI S.
The opposite effects of IL/15 and IL/21 on CLL B cells correlate with
differential activation of the JAK/STAT and ERK1/2 pathways.
Blood 111:517/524, 2008 - Epub Oct 15, 2007
PubMed Abstract
DONO M.-BURGIO V.-COLOMBO M.-SCIACCHITANO S.-REVERBERI D.-TARANTINO V.-CUTRONA G.-CHIORAZZI N.-FERRARINI M.
CD5+ B cells with the features of subepithelial B cells found in human tonsils.
Eur. J. Immunol. 37:2138/2147, 2007
PubMed Abstract
GARGIULO L.-LASTRAIOLI S.-CERRUTI G.-SERRA M.-LOIACONO F.-ZUPO S.-LUZZATTO L.-NOTARO R.
Highly homologous T cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal
nocturnal hemoglobinuria.
Blood 109:5036/5042, 2007
PubMed Abstract
MOLICA S.-CUTRONA G.-VITELLI G.-MIRABELLI R.-MOLICA M.-DIGIESI G.-RIBATTI D.-FERRARINI M.-VACCA A.
Markers of increased angiogenesis and their correlation with biological parameters identifying high risk patients in early B
cell chronic lymphocytic leukemia.
Leuk. Res. 31:1575/1578, 2007
PubMed Abstract
BOFFA L.-CUTRONA G.-CILLI M.-MATIS S.-DAMONTE G.-MARIANI M.-MILLO E.-MORONI M.-RONCELLA S.-FEDELI F.-FERRARINI M.
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c/myc.
Cancer Gene Ther. 14:220/226, 2007 - Epub Oct 20, 2006
PubMed Abstract
CHIORAZZI N.-FERRARINI M.
Evolving view of the in vivo kinetics of chronic lymphocytic leukemia B cells.
Hematology Am. Soc. Hematol. Educ. Program :273/278, 2006
PubMed Abstract
CUTRONA G.-COLOMBO M.-MATIS S.-REVERBERI D.-DONO M.-TARANTINO V.-CHIORAZZI N.-FERRARINI M.
B lymphocytes in humans express ZAP/70 when activated in vivo.
Eur. J. Immunol. 36:558/569, 2006
PubMed Abstract
DE TOTERO D.-MEAZZA R.-ZUPO S.-CUTRONA G.-MATIS S.-COLOMBO M.-BALLEARI E.-PIERRI I.-FABBI M.-CAPAIA M.-AZZARONE B.-GOBBI M.-
FERRARINI M.-FERRINI S.
Interleukin/21 receptor (IL/21R) is up regulated by CD40 triggering and mediates preapoptotic signals in chronic lymphocytic leukemia B cells.
Blood 107:3708/3715, 2006
PubMed Abstract
MIGLIETTA L.-FRANZONE P.-CENTURIONI M.G.-BONI L.-TACCHINI L.-COSSO M.-BOCCARDO F.-FERRARINI M.-BRUZZONE M.
A phase II trial with cisplatin/paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally
advanced or recurrent cervical cancer.
Oncology (Basel) 70:19/24, 2006
PubMed Abstract
ORTOLAN E.-TIBALDI E.-FERRANTI B.-LAVAGNO L.-GARBARINO G.-NOTARO R.-LUZZATTO L.-MALAVASI F.-FUNARO A.
CD157 plays a pivotal role in neutrophil transendothelial migration.
Blood 108:4214/4222, 2006
PubMed Abstract
PICCIOLI P.-SERRA M.-GISMONDI V.-PEDEMONTE S.-LOIACONO F.-LASTRAIOLI S.-BERTARIO L.-DE ANGIOLETTI M.-VARESCO L.- NOTARO R.
Multiplex tetra primer amplification refractory mutation system PCR to detect 6 common germline mutations of the MUTYH gene
associated with polyposis and colorectal cancer.
Clin. Chem. 52:739/743, 2006
PubMed Abstract
PILERI S.-PICCALUGA P.-AGOSTINELLI C.-ZUPO S.-FACCHETTI F.-FALINI B.-FERRARINI M.-GALLAMINI A.-NOVERO D.-PAULLI M.-ZINZANI P.-DALLA FAVERA R.
Gene expression analysis of peripheral T cell lymphoma not otherwise specified reveals two distinct subgroups and recurrent
PDGFR/alpha deregulation.
Haematologica Rep. 2:66/67, 2006
SABATTINI E.-ROCIO O.-CAMPIDELLI C.-ZINZANI P.-CALLEA V.-ZUPO S.-CUTRONA G.-MORABITO F.-FERRARINI M.-PILERI S.
B cell chronic lymphocytic leukaemia small lymphocytic lymphoma: role of ZAP/70 determination on bone marrow biopsies.
J. Clin. Pathol. 60:627/632, 2007 - Epub Aug 17, 2006
PubMed Abstract
UVA B.-STROLLO F.-RICCI F.-PASTORINO M.-TAGLIAFERRO G.-MARIANI M.-MASINI M.
Ions and water transmembrane transport in nervous and testicular cultured cells in low gravity conditions.
Microgravity Sci. Tec. 18:239/242, 2006
Per le pubblicazioni 2000-2005 del personale della struttura vedere gli
elenchi generali.
|
Presentazione della struttura